Skip to content

Released Mar 25, 2014, before the open

10-Q filed Mar 25, 2014, 176 days after period end · 0001193125-14-113186

Q3 2013 · 10-Q
Revenue$91.81M−13.2% vs Q3 2012−6.0% vs Q2 2013
Net Income-$18.84MN/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$1.04N/M vs Q3 2012N/M vs Q2 2013
Gross Profit$66,742,000−17.5%
Operating Income-$14,101,000N/M
Operating Cash Flowderived$17,766,000+67.0%
Free Cash Flowderived$11,165,000+113.9%
Margins · derived
Gross margin72.7%−3.8 pt vs Q3 2012
Operating margin-15.4%−31.4 pt vs Q3 2012
Net margin-20.5%−24.1 pt vs Q3 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2013Q3 2012Q3 2011Q3 2010
Revenue$91.81M$105.82M$111.51M$138.91M
Net Income-$18.84M$3.75M$10.08M$8.52M
EPS Diluted-$1.04$0.19$0.54$0.48

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR